DE2723876C2 - 17β-Ester von Testosteron - Google Patents

17β-Ester von Testosteron

Info

Publication number
DE2723876C2
DE2723876C2 DE2723876A DE2723876A DE2723876C2 DE 2723876 C2 DE2723876 C2 DE 2723876C2 DE 2723876 A DE2723876 A DE 2723876A DE 2723876 A DE2723876 A DE 2723876A DE 2723876 C2 DE2723876 C2 DE 2723876C2
Authority
DE
Germany
Prior art keywords
esters
acid
testosterone
ester
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2723876A
Other languages
German (de)
English (en)
Other versions
DE2723876A1 (de
Inventor
Johannes van der Oss Vies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/691,103 external-priority patent/US4098802A/en
Application filed by Akzo NV filed Critical Akzo NV
Publication of DE2723876A1 publication Critical patent/DE2723876A1/de
Application granted granted Critical
Publication of DE2723876C2 publication Critical patent/DE2723876C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE2723876A 1976-05-28 1977-05-26 17β-Ester von Testosteron Expired DE2723876C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/691,103 US4098802A (en) 1975-02-18 1976-05-28 Oral pharmaceutical preparation having androgenic activity

Publications (2)

Publication Number Publication Date
DE2723876A1 DE2723876A1 (de) 1977-12-15
DE2723876C2 true DE2723876C2 (de) 1986-10-30

Family

ID=24775172

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2723876A Expired DE2723876C2 (de) 1976-05-28 1977-05-26 17β-Ester von Testosteron

Country Status (12)

Country Link
JP (1) JPS52148060A (cs)
AR (1) AR214323A1 (cs)
BE (1) BE855163A (cs)
CH (1) CH627761A5 (cs)
DE (1) DE2723876C2 (cs)
DK (1) DK146096C (cs)
ES (1) ES459230A1 (cs)
FI (1) FI57597C (cs)
FR (1) FR2352832A1 (cs)
GB (1) GB1567515A (cs)
NL (1) NL7705790A (cs)
SE (1) SE425493B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2415349A1 (en) * 2000-08-23 2002-02-28 Akzo Nobel N.V. Testosterone ester formulation for human use
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
GB0807605D0 (en) 2008-04-28 2008-06-04 Diurnal Ltd Lipid composition
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
TW201521731A (zh) * 2013-03-15 2015-06-16 利波辛股份有限公司 用於口服之脂平衡的長鏈睪固酮酯
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
CA3107214A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Also Published As

Publication number Publication date
DK236877A (da) 1977-11-29
CH627761A5 (en) 1982-01-29
JPS52148060A (en) 1977-12-08
GB1567515A (en) 1980-05-14
SE425493B (sv) 1982-10-04
FI57597B (fi) 1980-05-30
JPS6145637B2 (cs) 1986-10-08
AR214323A1 (es) 1979-05-31
SE7706235L (sv) 1977-11-29
ES459230A1 (es) 1978-11-16
NL7705790A (nl) 1977-11-30
DK146096C (da) 1983-11-21
DE2723876A1 (de) 1977-12-15
FI57597C (fi) 1980-09-10
FI771684A7 (cs) 1977-11-29
FR2352832B1 (cs) 1980-07-11
BE855163A (fr) 1977-11-28
FR2352832A1 (fr) 1977-12-23
DK146096B (da) 1983-06-27

Similar Documents

Publication Publication Date Title
DE2624025C2 (cs)
US4083973A (en) Pharmaceutical preparation adapted for oral administration
DE69031033T2 (de) Verwendung von eicosapentaensäure zur behandlung der kachexie
DE69429513T2 (de) Polyphenolderivatzusammensetzungen und deren herstellung
DE2414680C2 (de) Substituierte 2-Furancarbonsäuren und 2-Furancarbonsäureester, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
EP0241809A1 (de) Synergistische Kombination von Amantadin und Selegilin
DE2549783C3 (de) Triglyceride mit entzündungshemmender Wirkung
DE69431965T2 (de) Wirkstoff gegen fettsucht
DE69512929T2 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
DE2723876C2 (de) 17β-Ester von Testosteron
DE69421366T2 (de) Staurosporinderivate und Polyalkylenglykol-Glyceride enthaltende Arzneimittel
LU84892A1 (fr) Komposition zur reduktion der sebumsekretion
DE69711633T2 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
DE2252637C3 (de) Verwendung von 1,3-Glycerindiäthern
DE2504045B2 (de) 16,17 dihydro-apovincaminsaeure-2- hydroxypropylester, deren salze, verfahren zu ihrer herstellung und arzneimittel
DE2748291A1 (de) Triglyceride, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von entzuendungen
DE2756866C2 (de) N-Oleoyl-Derivate von Phosphatidyläthanolaminen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2843811A1 (de) Retinsaeure- und 7,8-dehydro-retinsaeure-n-(carboxy)-phenylamide
DE69328585T2 (de) Neue Alkaloidderivate, ihre Verwendung und diese enthaltende pharmazeutische Formulierungen
DE1906322A1 (de) Neue alpha-Alkyl-5-hydroxytryptophanester
CH644133A5 (de) Oxydierte sterylglycosid-derivate und sie enthaltende pharmazeutische praeparate.
DE2055039C2 (de) Arzneimittel, enthaltend ein wasserlösliches Salz eines α-Tocopherol-Derivats
DE4333794A1 (de) Neue Acetyl-Salicylsäure-Derivate zur Bekämpfung von Entzündungs- und Schmerzzuständen sowie zur Thromboseprophylaxe und -terapie
CA1113926A (en) Pharmaceutical preparation adapted for oral administration
DE2515142B2 (de) Oral verabfolgbare mittel zur senkung des lipid- und cholesterin- spiegels

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee